P24135
Gene name |
Plcg2 |
Protein name |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 |
Names |
EC 3.1.4.11 , Phosphoinositide phospholipase C-gamma-2 , Phospholipase C-IV , PLC-IV , Phospholipase C-gamma-2 , PLC-gamma-2 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:29337 |
EC number |
3.1.4.11: Phosphoric diester hydrolases |
Protein Class |
|
Descriptions
Autoinhibitory domains (AIDs)
Target domain |
312-456 (Catalytic PLC X domain) |
Relief mechanism |
PTM, Partner binding |
Assay |
|
Target domain |
312-456 (Catalytic PLC X domain) |
Relief mechanism |
PTM, Partner binding |
Assay |
|
Target domain |
312-456 (Catalytic PLC X domain) |
Relief mechanism |
PTM, Partner binding |
Assay |
|
Accessory elements
No accessory elements
References
- Lowe J et al. (2022) "Conformational switches that control the TEC kinase - PLCγ signaling axis", Journal of structural biology: X, 6, 100061
- Bunney TD et al. (2012) "Structural and functional integration of the PLCγ interaction domains critical for regulatory mechanisms and signaling deregulation", Structure (London, England : 1993), 20, 2062-75
- Hajicek N et al. (2019) "Structural basis for the activation of PLC-γ isozymes by phosphorylation and cancer-associated mutations", eLife, 8,
- Devkota S et al. (2015) "Scaffold Protein SLP-76 Primes PLCγ1 for Activation by ITK-Mediated Phosphorylation", Journal of molecular biology, 427, 2734-47
- Kunze K et al. (2014) "A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells", Cancer research, 74, 6173-83
- DeBell K et al. (2007) "Intramolecular regulation of phospholipase C-gamma1 by its C-terminal Src homology 2 domain", Molecular and cellular biology, 27, 854-63
- Xie Q et al. (2013) "Substrate recognition of PLCγ1 via a specific docking surface on Itk", Journal of molecular biology, 425, 683-96
- Hajicek N et al. (2013) "Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes", Biochemistry, 52, 4810-9
Autoinhibited structure
Activated structure
2 structures for P24135
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 2EOB | NMR | - | A | 633-743 | PDB |
| AF-P24135-F1 | Predicted | AlphaFoldDB |
No variants for P24135
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P24135 | |||||
No associated diseases with P24135
4 regional properties for P24135
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | C2 domain | 430 - 560 | IPR000008 |
| domain | Phosphatidylinositol-specific phospholipase C, X domain | 112 - 256 | IPR000909 |
| domain | Phospholipase C, phosphatidylinositol-specific, Y domain | 313 - 430 | IPR001711 |
| domain | Phosphoinositide-specific phospholipase C, EF-hand-like domain | 27 - 102 | IPR015359 |
Functions
| Description | ||
|---|---|---|
| EC Number | 3.1.4.11 | Phosphoric diester hydrolases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
7 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| intracellular vesicle | Any vesicle that is part of the intracellular region. |
| membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| ruffle membrane | The portion of the plasma membrane surrounding a ruffle. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| phosphatidylinositol phospholipase C activity | Catalysis of the reaction |
| phosphorylation-dependent protein binding | Binding to a protein upon phosphorylation of the target protein. |
| phosphotyrosine residue binding | Binding to a phosphorylated tyrosine residue within a protein. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| protein tyrosine kinase binding | Binding to protein tyrosine kinase. |
| scaffold protein binding | Binding to a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes. |
55 GO annotations of biological process
| Name | Definition |
|---|---|
| antifungal innate immune response | An defense response against a fungus mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens. |
| B cell differentiation | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
| B cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
| calcium-mediated signaling | Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. |
| cell activation | A multicellular organismal process by which exposure to an activating factor such as a cellular or soluble ligand results in a change in the morphology or behavior of a cell. |
| cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| cellular response to lectin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lectin stimulus. A lectin is a carbohydrate-binding protein, highly specific for binding sugar moieties. |
| cellular response to lipid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus. |
| follicular B cell differentiation | The process in which a B cell in the spleen acquires the specialized features of a follicular B cell. Follicular B cells are major population of mature recirculating B cells in the spleen and are located in the B-cell follicle region. |
| inositol trisphosphate biosynthetic process | The chemical reactions and pathways resulting in the formation of inositol trisphosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached. |
| intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| lipopolysaccharide-mediated signaling pathway | The series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
| macrophage activation involved in immune response | A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| negative regulation of programmed cell death | Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. |
| phosphatidylinositol biosynthetic process | The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. |
| phosphatidylinositol metabolic process | The chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. |
| phosphatidylinositol-mediated signaling | The series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| phospholipid catabolic process | The chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester. |
| positive regulation of calcium-mediated signaling | Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling. |
| positive regulation of cell cycle G1/S phase transition | Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle. |
| positive regulation of cytosolic calcium ion concentration | Any process that increases the concentration of calcium ions in the cytosol. |
| positive regulation of dendritic cell cytokine production | Any process that activates or increases the frequency, rate, or extent of dendritic cell cytokine production. |
| positive regulation of DNA-binding transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| positive regulation of epithelial cell migration | Any process that activates or increases the frequency, rate or extent of epithelial cell migration. |
| positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of I-kappaB phosphorylation | Any process that activates or increases the frequency, rate or extent of I-kappaB phosphorylation. |
| positive regulation of interleukin-10 production | Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. |
| positive regulation of interleukin-12 production | Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
| positive regulation of interleukin-2 production | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
| positive regulation of interleukin-23 production | Any process that activates or increases the frequency, rate, or extent of interleukin-23 production. |
| positive regulation of interleukin-6 production | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| positive regulation of macrophage cytokine production | Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| positive regulation of neuroinflammatory response | Any process that activates or increases the frequency, rate or extent of neuroinflammatory response. |
| positive regulation of NLRP3 inflammasome complex assembly | Any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
| positive regulation of peptidyl-tyrosine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| positive regulation of phagocytosis, engulfment | Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis. |
| positive regulation of reactive oxygen species biosynthetic process | Any process that activates or increases the frequency, rate or extent of reactive oxygen species biosynthetic process. |
| positive regulation of receptor internalization | Any process that activates or increases the frequency, rate or extent of receptor internalization. |
| positive regulation of tumor necrosis factor production | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
| positive regulation of type I interferon production | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
| programmed cell death | A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell. |
| regulation of calcineurin-NFAT signaling cascade | Any process that modulates the frequency, rate or extent of the calcineurin-NFAT signaling cascade. |
| regulation of canonical NF-kappaB signal transduction | Any process that modulates I-kappaB kinase/NF-kappaB signaling. |
| regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| regulation of lipid metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipids. |
| release of sequestered calcium ion into cytosol | The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment. |
| response to ATP | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus. |
| response to axon injury | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus. |
| response to lipopolysaccharide | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| response to magnesium ion | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. |
| response to yeast | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species. |
| stimulatory C-type lectin receptor signaling pathway | The series of molecular signals initiated by the binding of C-type lectin to its receptor on the surface of a target cell, and resulting in cellular activation. |
| T cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. |
| toll-like receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a toll-like receptor of a target cell. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response. |
17 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P08487 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Bos taurus (Bovine) | EV SS |
| P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Homo sapiens (Human) | EV |
| P16885 | PLCG2 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 | Homo sapiens (Human) | SS |
| Q62077 | Plcg1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Mus musculus (Mouse) | SS |
| P10686 | Plcg1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Rattus norvegicus (Rat) | EV |
| O89040 | Plcb2 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 | Rattus norvegicus (Rat) | PR |
| P10687 | Plcb1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Rattus norvegicus (Rat) | SS |
| Q99P84 | Plce1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 | Rattus norvegicus (Rat) | EV |
| P10688 | Plcd1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 | Rattus norvegicus (Rat) | SS |
| Q99JE6 | Plcb3 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 | Rattus norvegicus (Rat) | SS |
| Q39032 | PLC1 | Phosphoinositide phospholipase C 1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q56W08 | PLC3 | Phosphoinositide phospholipase C 3 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q6NMA7 | PLC9 | Phosphoinositide phospholipase C 9 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q8GV43 | PLC6 | Phosphoinositide phospholipase C 6 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q944C2 | PLC5 | Phosphoinositide phospholipase C 5 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9STZ3 | PLC8 | Phosphoinositide phospholipase C 8 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q944C1 | PLC4 | Phosphoinositide phospholipase C 4 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTTMVNVDTL | PEYEKSQIKR | ALELGTVMTV | FSARKSTPER | RTVQMIMETR | QVAWSKTADK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| IEGFLDIMEI | KEIRPGKNSK | DFERAKAVRH | KADCCFTIFY | GTQFVLSTLS | LATDSKEDAV |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KWLSGLKILH | QEAMNASTPT | MIESWLRKQI | YSVDQTRRNS | ISLRELKTIL | PLVNFKVSGI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KFLKDKLVEI | GAQKDELSFE | QFHLFYKKLM | FEQQKSILDE | FKKDSSVFIL | GNTDRPDASA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VYLQDFQRFL | LHEQQELWAQ | DLNKVRERMT | KFIDDTMRET | AEPFLFVDEF | LTYLFSRENS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IWDEKYDAVD | MQDMNNPLSH | YWISSSHNTY | LTGDQLRSES | STEAYIRCLR | AGCRCIELDC |
| 370 | 380 | 390 | 400 | 410 | 420 |
| WDGPDGKPII | YHGWTRTTKI | KFDDVVQAIR | DHAFVTSSFP | VILSIEEHCS | VEQQRHMAKV |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FKEVLGDLLL | TKPTEASADQ | LPSPSQLREK | IIIKHKKLGP | RGDVDVNVED | KKDEHKTQGE |
| 490 | 500 | 510 | 520 | 530 | 540 |
| LYMWDSIDQK | WTRHYCAIAD | AKLSFSDDIE | QTVEEDPVQD | TPPTELHFGE | KWFHKKVESR |
| 550 | 560 | 570 | 580 | 590 | 600 |
| TSAEKLLQEY | CAETGAKDGT | FLVRESETFP | NDYTLSFWRS | GRVQHCRIRS | TMEGGVMKYY |
| 610 | 620 | 630 | 640 | 650 | 660 |
| LTDNLTFNSI | YALIQHYREA | HLRCAEFELR | LTDPVPNPNP | HESKPWYYDR | LSRGEAEDML |
| 670 | 680 | 690 | 700 | 710 | 720 |
| MRIPRDGAFL | IRKREGTDSY | AITFRARGKV | KHCRINRDGR | HFVLGTSAYF | ESLVELVSYY |
| 730 | 740 | 750 | 760 | 770 | 780 |
| EKHALYRKMR | LRYPVTPELL | ERYNMERDIN | SLYDVSRMYV | DPSEINPSMP | QRTVKALYDY |
| 790 | 800 | 810 | 820 | 830 | 840 |
| KAKRSDELTF | CRGALIHNVS | KEPGGWWKGD | YGTRIQQYFP | SNYVEDISAG | DAEEMEKQII |
| 850 | 860 | 870 | 880 | 890 | 900 |
| EDNPLGSLCR | GILDLNTYNV | VKAPQGKNQK | AFVFILEPKK | QGDPPVEFAT | DRVEELFEWF |
| 910 | 920 | 930 | 940 | 950 | 960 |
| QSIREITWKI | DTKENNMKYW | ERNQSIAIEL | SDLVVYCKPT | SKTKDHLENP | DFREIRSFVE |
| 970 | 980 | 990 | 1000 | 1010 | 1020 |
| TKADSIVRQK | PVDLLRYNQK | GLTRVYPKGQ | RVDSSNYDPF | RLWLCGSQMV | ALNFQTPDKY |
| 1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
| MQMNHALFSL | NGRTGYVLQP | ESMRSEKYDP | MPPESQRKIL | MTLTVKVLGA | RHLPKLGRSI |
| 1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
| ACPFVEVEIC | GAEYDSNKFK | TTVVNDNGLS | PVWAPTQEKV | TFEIYDPNLA | FLRFLVYEED |
| 1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
| MFSDPNFLAH | ATYPIKGIKS | GFRSVPLKNG | YSEDIELASL | LVFCEMRPVL | ESEEELYSSC |
| 1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
| RQLRRRQEEL | NNQLFLYDTH | QNLRGANRDA | LVKEFNVNEN | QLRLYQEKCN | RRLREKRVSN |
| SRFYS |